DC
SGYP

Deere & Company’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Deere & Company’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-112,919
Closed -$429K – 1141
2016
Q2 		$429K Buy
+112,919
New +$383K 0.02% 707

Other funds holding SGYP

TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Deere & Company's SGYP Position: Q3 2016 in Review

Deere & Company sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q3 2016, closing a stake of 112,919 shares — an estimated $429K sold.

Deere & Company first reported a position in SGYP in Q2 2016 and held it in 1 quarter. The position peaked at $429K in Q2 2016. 149 funds tracked by Wall St. Rank hold SGYP as of Q3 2016.

  • Deere & Company reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q3 2016 after selling out during the quarter.
  • Deere & Company sold 112,919 Synergy Pharmaceuticals, Inc Common Stock shares in Q3 2016, an estimated $429K.
  • Deere & Company first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2016 and held it in 1 quarter.
  • Deere & Company's Synergy Pharmaceuticals, Inc Common Stock position peaked at $429K in Q2 2016.
  • 149 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q3 2016.

Based on Deere & Company's 13F filing for Q3 2016, filed 14 Nov 2016.